GB201306569D0 - Tannin extract of sanguisorba officinalis L. and preparation method and use thereof - Google Patents

Tannin extract of sanguisorba officinalis L. and preparation method and use thereof

Info

Publication number
GB201306569D0
GB201306569D0 GBGB1306569.3A GB201306569A GB201306569D0 GB 201306569 D0 GB201306569 D0 GB 201306569D0 GB 201306569 A GB201306569 A GB 201306569A GB 201306569 D0 GB201306569 D0 GB 201306569D0
Authority
GB
United Kingdom
Prior art keywords
sanguisorba officinalis
preparation
tannin extract
extract
tannin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1306569.3A
Other versions
GB2497899B (en
GB2497899A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENGDU KEER PHARMACEUTICAL CO Ltd
Original Assignee
CHENGDU KEER PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDU KEER PHARMACEUTICAL CO Ltd filed Critical CHENGDU KEER PHARMACEUTICAL CO Ltd
Publication of GB201306569D0 publication Critical patent/GB201306569D0/en
Publication of GB2497899A publication Critical patent/GB2497899A/en
Application granted granted Critical
Publication of GB2497899B publication Critical patent/GB2497899B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739—Sanguisorba (burnet)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

A tannin extract of Sanguisorba officinalis L. contains tannin in a range of 35%-100% (w/w), wherein the content of total saponin is less than 10% (w/w), and the content of sanguisorbin I is less than 5% (w/w). The extract can protect bone marrow hematopoietic stem cells, relieve the inhibition of mouse bone marrow DNA caused by drugs for radiation therapy and chemotherapy, as well as increase numbers of leucocytes.
GB1306569.3A 2010-09-14 2011-09-14 Sanguiin for use in the prevention or treatment of bone marrow inhibition Active GB2497899B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010280772 2010-09-14
CN201110186932 2011-07-05
PCT/CN2011/079633 WO2012034519A1 (en) 2010-09-14 2011-09-14 Tannin extract of sanguisorba officinalis l. and preparation method and use thereof

Publications (3)

Publication Number Publication Date
GB201306569D0 true GB201306569D0 (en) 2013-05-22
GB2497899A GB2497899A (en) 2013-06-26
GB2497899B GB2497899B (en) 2018-05-30

Family

ID=45831012

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1306569.3A Active GB2497899B (en) 2010-09-14 2011-09-14 Sanguiin for use in the prevention or treatment of bone marrow inhibition

Country Status (5)

Country Link
CN (3) CN103784434A (en)
GB (1) GB2497899B (en)
MY (1) MY173437A (en)
SG (2) SG10201505752QA (en)
WO (1) WO2012034519A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103223036A (en) * 2013-04-16 2013-07-31 阚兆云 Traditional Chinese medicinal composition
CN104435220B (en) * 2013-09-22 2018-01-05 成都百草和济科技有限公司 Treat the combination medicine of bone marrow suppression
CN104623015A (en) * 2013-11-08 2015-05-20 成都百草和济科技有限公司 New application of garden burnet root and India madder root composition
GB201413228D0 (en) 2014-07-25 2014-09-10 Nugerontix Ltd Polyphenol compositions
CN105147804B (en) * 2015-08-28 2019-04-09 四川英路维特医药科技有限公司 A kind of radix sanguisorbae total saponin extract and its preparation method and application
US10155069B2 (en) 2016-09-09 2018-12-18 King Abdulaziz University Bone graft with a tannin-hydroxyapatite scaffold and stem cells for bone engineering
CN112876523B (en) * 2021-03-30 2023-07-25 江西海富生物工程有限公司 Method for recovering tannic acid from fructus momordicae, sweet tea or stevia rebaudiana floc residues
CN114577970B (en) * 2022-02-18 2023-05-12 江西普正制药股份有限公司 Method for establishing blood level tablet fingerprint and fingerprint thereof
CN115232516B (en) * 2022-06-27 2023-06-06 中南林业科技大学 Anti-adhesion coating with camellia saponin as main component, preparation method thereof and application thereof in inhibiting bacillus cereus
CN115998703A (en) * 2022-12-14 2023-04-25 迪沙药业集团有限公司 Sanguisorba composition and preparation method thereof
CN116688012B (en) * 2023-07-05 2024-06-04 浙江工业大学 Buccal tablet for preventing influenza

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58103383A (en) * 1981-12-12 1983-06-20 Nippon Shinyaku Co Ltd New tannin
JPS58154571A (en) * 1982-03-08 1983-09-14 Nippon Shinyaku Co Ltd Novel tannin
CN1824631A (en) * 2005-12-29 2006-08-30 谢君 Molecular modification method of active fat soluble plant polyphenol kind substance
JP2010070540A (en) * 2008-08-22 2010-04-02 Kao Corp Dgat inhibitor

Also Published As

Publication number Publication date
WO2012034519A1 (en) 2012-03-22
CN103948710A (en) 2014-07-30
CN103784434A (en) 2014-05-14
GB2497899B (en) 2018-05-30
SG188529A1 (en) 2013-04-30
GB2497899A (en) 2013-06-26
MY173437A (en) 2020-01-24
SG10201505752QA (en) 2015-09-29
CN103079560A (en) 2013-05-01

Similar Documents

Publication Publication Date Title
GB201306569D0 (en) Tannin extract of sanguisorba officinalis L. and preparation method and use thereof
MX2010003934A (en) Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium.
WO2012159085A3 (en) Compositions and methods for treating and preventing cancer by targeting and inhibiting cancer stem cells
WO2013027984A3 (en) Cosmetic composition containing green tea component
IN2015DN02729A (en)
WO2010095911A3 (en) Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient
WO2012050398A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
MX2014000150A (en) Systems, methods, and formulations for treating cancer.
SG178593A1 (en) Use of lanostanes and extracts from poria cocos for treating diabetes
MX2013006319A (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer.
NZ701133A (en) Composition for treating metabolic disorders
WO2012134169A3 (en) Composition for lung cancer treatment and functional food containing gleditsiae semen extract
GB2525517A (en) Topical preparation for pain relief
WO2012108749A3 (en) Composition and health functional food for treating brain cancer comprising pharbitidis semen extract
CN104446920A (en) Nutrient liquid capable of preventing and treating soft rot disease of dendrobium officinale
SG179069A1 (en) Cancer stem cell-targeted and drug resistant cancer therapy
MX2015006370A (en) Herbal supplements and methods of use thereof.
MX2009011901A (en) Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer.
CN104447081A (en) Nutrient solution for preventing and curing diaspididae of dendrobii officmalis caulis
MX2014010926A (en) Herbal composition for the treatment of metabolic disorders.
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
MY170190A (en) Use of a fermented soy extract as a prebiotic composition
CN105982925A (en) Traditional Chinese medicine composition for treating urinary calculi
WO2012134250A3 (en) Composition for renal cancer treatment and composition for cosmetic containing nardostachyos rhizoma extract
WO2012134168A3 (en) Composition for lung cancer treatment and composition for cosmetics containing lysimachiae foenumgraeci herba extract

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20200227 AND 20200304